|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08189 TEDA BIOMEDICAL
Nominal 
0.290 0.000 (0.000%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 62,692 | 73,627 | 78,762 | 79,573 |
| Land & other Lease Assets | -- | -- | 35,662 | 39,309 | 53,286 | 59,237 |
| Intangible Assets | -- | -- | 0 | 0 | 12,074 | 37 |
| Interests in Asso. & JCEs | -- | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | -- | -- | 180 | 0 | 0 | 0 |
| -- | -- | 98,533 | 112,936 | 144,122 | 138,847 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Inventories | -- | -- | 75,308 | 90,457 | 74,004 | 75,221 | |
| Trade Receivables | -- | -- | 10,819 | 8,777 | 31,867 | 32,082 | |
| Cash & Bank Balances | -- | -- | 25,400 | 5,934 | 6,856 | 26,439 | |
| Other Current Assets | -- | -- | 122,467 | 70,420 | 80,347 | 70,058 | |
| Assets Held for Sale | -- | -- | 0 | 14,754 | 0 | 4,948 | |
| -- | -- | 233,994 | 190,342 | 193,075 | 208,749 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 8,932 | 16,107 | 20,723 | 29,533 | ||
| S-T Debt & Leases | -- | -- | 136,231 | 56,669 | 67,372 | 45,131 | ||
| Other Current Liabilities | -- | -- | 133,902 | 133,991 | 130,154 | 117,360 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 0 | 10,076 | 0 | 0 | ||
| -- | -- | 279,065 | 216,842 | 218,249 | 192,024 | |||
| Net Current Assets | -- | -- | (45,071) | (26,500) | (25,175) | 16,725 | ||
| Total Assets Less Current Liabilities | -- | -- | 53,462 | 86,436 | 118,947 | 155,572 | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 23,684 | 20,295 | 35,234 | 45,212 | |||
| Other Non-current Liabilities | -- | -- | 1,338 | 1,561 | 2,564 | 0 | |||
| -- | -- | 25,022 | 21,856 | 37,797 | 45,212 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 189,450 | 189,450 | 189,450 | 189,450 | ||||
| Reserves | -- | -- | (167,301) | (139,499) | (119,339) | (88,669) | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 22,149 | 49,951 | 70,111 | 100,781 | ||||
| Non-controlling Interests | -- | -- | 6,291 | 14,628 | 11,039 | 9,579 | ||||
| Others | -- | -- | 0 | 0 | 0 | 0 | ||||
| -- | -- | 28,440 | 64,579 | 81,150 | 110,359 | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 0 | 800 | 2,403 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 02/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -90,820 |
| %Change | 226.666% |
| EPS / (LPS) | RMB -0.044 |
| NBV Per Share (¥) | RMB -- |